Status:

UNKNOWN

Softened Water for Eczema Prevention Pilot Trial

Lead Sponsor:

King's College London

Collaborating Sponsors:

Guy's and St Thomas' NHS Foundation Trust

University of Nottingham

Conditions:

Atopic Eczema

Eligibility:

All Genders

Phase:

NA

Brief Summary

An outcome assessor-blinded pilot randomised controlled trial of an ion-exchange water softener for the prevention of atopic eczema in neonates, with an embedded mechanistic study

Detailed Description

A 6-month parallel group assessor-blinded pilot randomised controlled trial of an ion-exchange water softener for the prevention of eczema in neonates, with an embedded mechanistic study. The overall...

Eligibility Criteria

Inclusion

  • Participant (i.e. the neonate) must have a parent or sibling with a history of doctor-diagnosed atopy (i.e. at least one of: eczema, asthma, hayfever)
  • Mother aged ≥18 years of age at enrolment
  • Baby \<36 weeks gestation at screening
  • Informed consent from the mother on behalf of the participant
  • Mother has the ability to understand English
  • Live in a hard water area (\>250 mg/L Calcium Carbonate)
  • Consent of landlord for installation on water softener (if appropriate)
  • Occupy a property appropriate for installation of a water softener

Exclusion

  • Preterm birth (defined as birth prior to 37 weeks gestation)
  • Significant inflammatory skin disease at birth not including seborrheic dermatitis ("cradle cap")
  • Sibling (including twin) previously randomised to this trial. If multiple birth, the first child will be randomised into the trial.
  • The child is to be fostered/adopted
  • Any immunodeficiency disorder or severe genetic skin disorder
  • Child has any other serious health issue which, at parent or investigator discretion, would make it difficult for the family to take part in the trial.
  • Planned stays away from home for a continuous period of more than 2 weeks or a total of 1 month out of the 6 month follow up period
  • Water softening or filtration device already installed
  • Concurrent enrolment in any other skin-related intervention study
  • Other medical condition that in the opinion of the CI could interfere with the conduct of the trial

Key Trial Info

Start Date :

February 12 2018

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2019

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT03270566

Start Date

February 12 2018

End Date

June 1 2019

Last Update

February 19 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

St Thomas' Hospital

London, United Kingdom, SE1 7EH